These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9460870)

  • 21. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a.
    Dharmasena MN; Hanisch BW; Wai TT; Kopecko DJ
    Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunosuppressive activity of chemically modified lipopolysaccharide of Shigella sonnei.
    Vikström EV
    Immunol Lett; 2002 Jan; 80(1):15-9. PubMed ID: 11716960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lipopolysaccharide changes in smooth-type avirulent Shigella in comparison with initial virulent strains].
    Nikolaeva AI; Nastichkin IA; Kabanova EA; Lapina EB; Krukovets IL
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):15-8. PubMed ID: 1441805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relation of the immunosuppressivity of virulent Shigella to the structure of O antigen].
    Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Feb; (2):63-7. PubMed ID: 2452538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular cloning and characterization of the genetic determinants that express the complete Shigella serotype D (Shigella sonnei) lipopolysaccharide in heterologous live attenuated vaccine strains.
    Viret JF; Cryz SJ; Lang AB; Favre D
    Mol Microbiol; 1993 Jan; 7(2):239-52. PubMed ID: 7680409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nonspecific Shigella suppression of delayed hypersensitivity].
    Borisov VA; Frolov AF
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Mar; (3):21-4. PubMed ID: 7043973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further characterization of Shigella sonnei live vaccine candidates WRSs2 and WRSs3-plasmid composition, invasion assays and Sereny reactions.
    Bedford L; Fonseka S; Boren T; Ranallo RT; Suvarnapunya AE; Lee JE; Barnoy S; Venkatesan MM
    Gut Microbes; 2011; 2(4):244-51. PubMed ID: 21983066
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of a lipopolysaccharide encoded by a recombinant Shigella sonnei plasmid in Escherichia coli K-12.
    Seltmann G; Knirel YA; Shashkov AS; Tschäpe H
    Zentralbl Bakteriol; 1992 Dec; 277(4):419-28. PubMed ID: 1284653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The plasmid heterogeneity of Shigella sonnei phase-I and -II strains].
    Kaminskiĭ GD; Krupenko MA
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Nov; (11):28-32. PubMed ID: 2694691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of the structural components of bacterial lipopolysaccharide in its inductive immunosuppressive activity].
    Borisova EV
    Mikrobiol Z; 1999; 61(6):36-41. PubMed ID: 10707531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of variant plasmid forms of a bivalent Salmonella typhi-Shigella sonnei vaccine strain.
    Hartman AB; Ruiz MM; Schultz CL
    J Clin Microbiol; 1991 Jan; 29(1):27-32. PubMed ID: 1993762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlation between the loss of plasmid DNA and the transition from virulent phase I to avirulent phase II in Shigella sonnei].
    Sansonetti P; David M; Toucas M
    C R Seances Acad Sci D; 1980 Mar; 290(13):879-82. PubMed ID: 6771038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentration of milk secretory immunoglobulin A against Shigella virulence plasmid-associated antigens as a predictor of symptom status in Shigella-infected breast-fed infants.
    Hayani KC; Guerrero ML; Morrow AL; Gomez HF; Winsor DK; Ruiz-Palacios GM; Cleary TG
    J Pediatr; 1992 Dec; 121(6):852-6. PubMed ID: 1447644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Shigella toxicity in immunological tolerance].
    Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):95-9. PubMed ID: 2448979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of O-antigen gene clusters of Escherichia coli (Shigella) sonnei and Plesiomonas shigelloides O17: sonnei gained its current plasmid-borne O-antigen genes from P. shigelloides in a recent event.
    Shepherd JG; Wang L; Reeves PR
    Infect Immun; 2000 Oct; 68(10):6056-61. PubMed ID: 10992522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interaction of Shigella sonnei phase-I strains carrying F'- or R386 plasmids with continuous HeLa- and L-line cells].
    Miroliubova LV; Nastichkin IA; Petrovskaia VG
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Nov; (11):17-21. PubMed ID: 6318481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunosuppressive properties of virulent Shigella strains].
    Borisova EB
    Mikrobiol Z; 2000; 62(1):64-72. PubMed ID: 11300086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal immunoglobulin A responses in rabbits to a Salmonella typhi strain harboring a Shigella sonnei plasmid.
    Keren DF; Collins HH; Baron LS; Kopecko DJ; Formal SB
    Infect Immun; 1982 Jul; 37(1):387-9. PubMed ID: 7049953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning of regions required for contact hemolysis and entry into LLC-MK2 cells from Shigella sonnei form I plasmid: virF is a positive regulator gene for these phenotypes.
    Kato J; Ito K; Nakamura A; Watanabe H
    Infect Immun; 1989 May; 57(5):1391-8. PubMed ID: 2651305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.